FDA 483 - LSNE Madison LLC - October 11, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspection of Lyophilization Services of New England (LSNE) (Doing Business As PCI) in Madison, WI, revealed significant deficiencies in aseptic processing, environmental monitoring, and contamination control for sterile drug products. The firm failed to establish and follow adequate procedures to prevent microbial contamination, maintain equipment, and ensure product quality. These issues indicate a high severity of non-compliance across multiple critical manufacturing areas.
ID · 96855540-ce5b-45e8-b1a0-a26cfcf88f94